PET/CT in the evaluation of the treatment response in lymphomas Lenfomalarda tedavi yanıtının değerlendirilmesinde PET/BT

Mütevelizade G. Y.

Nuclear Medicine Seminars, cilt.7, sa.2, ss.177-186, 2021 (Scopus) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 7 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/nts.galenos.2021.0017
  • Dergi Adı: Nuclear Medicine Seminars
  • Derginin Tarandığı İndeksler: Scopus, EMBASE
  • Sayfa Sayıları: ss.177-186
  • Anahtar Kelimeler: F-18 FDG PET/CT, Lymphoma, Treatment response
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

The Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is a functional and metabolic imaging modality with high sensitivity and accuracy for staging, restaging, and evaluation of response to treatment in Non-Hodgkin and Hodgkin lymphoma patients. Objective and accurate evaluation of treatment response in interim (iPET) and end of treatment (ePET) PET/CT is one of the most important parameters of patient management. In this review, standardization studies used in the evaluation of treatment response with PET/CT in lymphomas, the importance of iPET and ePET in patient management, metabolic tumor markers and pitfalls that can be followed in PET/CT after treatment were evaluated.